Medtronic's doc payments draw new fire

Careful with that checkbook, Medtronic. Sen. Charles Grassley--who's been investigating financial ties between doctors and drug/device companies--is asking the device maker for info on any payments it's made to doctors since it paid $40 million to settle a kickback case last year.

Medtronic says it's only written legitimate checks for legitimate consulting work on device development. Several doctors have reaped six-figure payments in recent months. The person who flagged these payments for the Senate is also a lawyer representing the kickback whistleblower, who filed an additional complaint against Medtronic in early 2006.

- see this The Pioneer Press article for more 

Related Articles:
FDA's showdown with Grassley to delay nomination. Report
Grassley attacks FDA over its handling of Avandia. Report
Medtronic will settle accusations on kickbacks. Report

Suggested Articles

At one point, Novartis even offered up $90 apiece for the inclisiran developer but would later say even $85 was too much, a securities filing shows.

Sanofi spent months hyping its Tuesday investor event, and new CEO Paul Hudson certainly laid out a different vision for the drugmaker at the confab.

After more than 10 years as partners, Sanofi and Regeneron are splitting up their deal to comarket PCSK9 med Praluent and immunology drug Kevzara.